By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy
- Home
- IT & Telecommunication
- Report Detail
Highlights
The global Cancer Diagnostics Service market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Cancer Diagnostics Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Cancer Diagnostics Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Cancer Diagnostics Service in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Cancer Diagnostics Service include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, Abbott, QIAGEN, Siemens Healthcare GmbH and Thermo Fisher Scientific, Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cancer Diagnostics Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Diagnostics Service.
The Cancer Diagnostics Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cancer Diagnostics Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Diagnostics Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Illumina
- BGI Genomics Co.,Ltd.
- Agilent Technologies
- Macrogen
- Pacific Biosciences
- Abbott
- QIAGEN
- Siemens Healthcare GmbH
- Thermo Fisher Scientific, Inc.
- Applied DNA Sciences
Segment by Type
- Breast Cancer
- Blood Cancer
- Lung Cancer
- Colorectal Cancer
- Ovarian Cancer
- Others
Segment by Application
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Others
By Region
- North America
- - United States
- - Canada
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- - Nordic Countries
- - Rest of Europe
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Australia
- - Rest of Asia
- Latin America
- - Mexico
- - Brazil
- - Rest of Latin America
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE
- - Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Diagnostics Service companiesÂ’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Diagnostics Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Breast Cancer
1.2.3 Blood Cancer
1.2.4 Lung Cancer
1.2.5 Colorectal Cancer
1.2.6 Ovarian Cancer
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cancer Diagnostics Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Diagnostics Service Market Perspective (2018-2029)
2.2 Cancer Diagnostics Service Growth Trends by Region
2.2.1 Global Cancer Diagnostics Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cancer Diagnostics Service Historic Market Size by Region (2018-2023)
2.2.3 Cancer Diagnostics Service Forecasted Market Size by Region (2024-2029)
2.3 Cancer Diagnostics Service Market Dynamics
2.3.1 Cancer Diagnostics Service Industry Trends
2.3.2 Cancer Diagnostics Service Market Drivers
2.3.3 Cancer Diagnostics Service Market Challenges
2.3.4 Cancer Diagnostics Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Diagnostics Service Players by Revenue
3.1.1 Global Top Cancer Diagnostics Service Players by Revenue (2018-2023)
3.1.2 Global Cancer Diagnostics Service Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Diagnostics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Diagnostics Service Revenue
3.4 Global Cancer Diagnostics Service Market Concentration Ratio
3.4.1 Global Cancer Diagnostics Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Service Revenue in 2022
3.5 Cancer Diagnostics Service Key Players Head office and Area Served
3.6 Key Players Cancer Diagnostics Service Product Solution and Service
3.7 Date of Enter into Cancer Diagnostics Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Diagnostics Service Breakdown Data by Type
4.1 Global Cancer Diagnostics Service Historic Market Size by Type (2018-2023)
4.2 Global Cancer Diagnostics Service Forecasted Market Size by Type (2024-2029)
5 Cancer Diagnostics Service Breakdown Data by Application
5.1 Global Cancer Diagnostics Service Historic Market Size by Application (2018-2023)
5.2 Global Cancer Diagnostics Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cancer Diagnostics Service Market Size (2018-2029)
6.2 North America Cancer Diagnostics Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cancer Diagnostics Service Market Size by Country (2018-2023)
6.4 North America Cancer Diagnostics Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Diagnostics Service Market Size (2018-2029)
7.2 Europe Cancer Diagnostics Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cancer Diagnostics Service Market Size by Country (2018-2023)
7.4 Europe Cancer Diagnostics Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Diagnostics Service Market Size (2018-2029)
8.2 Asia-Pacific Cancer Diagnostics Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cancer Diagnostics Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer Diagnostics Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Diagnostics Service Market Size (2018-2029)
9.2 Latin America Cancer Diagnostics Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cancer Diagnostics Service Market Size by Country (2018-2023)
9.4 Latin America Cancer Diagnostics Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Diagnostics Service Market Size (2018-2029)
10.2 Middle East & Africa Cancer Diagnostics Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Cancer Diagnostics Service Introduction
11.1.4 Illumina Revenue in Cancer Diagnostics Service Business (2018-2023)
11.1.5 Illumina Recent Development
11.2 BGI Genomics Co.,Ltd.
11.2.1 BGI Genomics Co.,Ltd. Company Detail
11.2.2 BGI Genomics Co.,Ltd. Business Overview
11.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Introduction
11.2.4 BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2018-2023)
11.2.5 BGI Genomics Co.,Ltd. Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Cancer Diagnostics Service Introduction
11.3.4 Agilent Technologies Revenue in Cancer Diagnostics Service Business (2018-2023)
11.3.5 Agilent Technologies Recent Development
11.4 Macrogen
11.4.1 Macrogen Company Detail
11.4.2 Macrogen Business Overview
11.4.3 Macrogen Cancer Diagnostics Service Introduction
11.4.4 Macrogen Revenue in Cancer Diagnostics Service Business (2018-2023)
11.4.5 Macrogen Recent Development
11.5 Pacific Biosciences
11.5.1 Pacific Biosciences Company Detail
11.5.2 Pacific Biosciences Business Overview
11.5.3 Pacific Biosciences Cancer Diagnostics Service Introduction
11.5.4 Pacific Biosciences Revenue in Cancer Diagnostics Service Business (2018-2023)
11.5.5 Pacific Biosciences Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Cancer Diagnostics Service Introduction
11.6.4 Abbott Revenue in Cancer Diagnostics Service Business (2018-2023)
11.6.5 Abbott Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Detail
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Cancer Diagnostics Service Introduction
11.7.4 QIAGEN Revenue in Cancer Diagnostics Service Business (2018-2023)
11.7.5 QIAGEN Recent Development
11.8 Siemens Healthcare GmbH
11.8.1 Siemens Healthcare GmbH Company Detail
11.8.2 Siemens Healthcare GmbH Business Overview
11.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Introduction
11.8.4 Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2018-2023)
11.8.5 Siemens Healthcare GmbH Recent Development
11.9 Thermo Fisher Scientific, Inc.
11.9.1 Thermo Fisher Scientific, Inc. Company Detail
11.9.2 Thermo Fisher Scientific, Inc. Business Overview
11.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Introduction
11.9.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2018-2023)
11.9.5 Thermo Fisher Scientific, Inc. Recent Development
11.10 Applied DNA Sciences
11.10.1 Applied DNA Sciences Company Detail
11.10.2 Applied DNA Sciences Business Overview
11.10.3 Applied DNA Sciences Cancer Diagnostics Service Introduction
11.10.4 Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2018-2023)
11.10.5 Applied DNA Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cancer Diagnostics Service Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Breast Cancer
Table 3. Key Players of Blood Cancer
Table 4. Key Players of Lung Cancer
Table 5. Key Players of Colorectal Cancer
Table 6. Key Players of Ovarian Cancer
Table 7. Key Players of Others
Table 8. Global Cancer Diagnostics Service Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Cancer Diagnostics Service Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Cancer Diagnostics Service Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Cancer Diagnostics Service Market Share by Region (2018-2023)
Table 12. Global Cancer Diagnostics Service Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Cancer Diagnostics Service Market Share by Region (2024-2029)
Table 14. Cancer Diagnostics Service Market Trends
Table 15. Cancer Diagnostics Service Market Drivers
Table 16. Cancer Diagnostics Service Market Challenges
Table 17. Cancer Diagnostics Service Market Restraints
Table 18. Global Cancer Diagnostics Service Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Cancer Diagnostics Service Market Share by Players (2018-2023)
Table 20. Global Top Cancer Diagnostics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2022)
Table 21. Ranking of Global Top Cancer Diagnostics Service Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Cancer Diagnostics Service Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cancer Diagnostics Service Product Solution and Service
Table 25. Date of Enter into Cancer Diagnostics Service Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cancer Diagnostics Service Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Cancer Diagnostics Service Revenue Market Share by Type (2018-2023)
Table 29. Global Cancer Diagnostics Service Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Cancer Diagnostics Service Revenue Market Share by Type (2024-2029)
Table 31. Global Cancer Diagnostics Service Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Cancer Diagnostics Service Revenue Market Share by Application (2018-2023)
Table 33. Global Cancer Diagnostics Service Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Cancer Diagnostics Service Revenue Market Share by Application (2024-2029)
Table 35. North America Cancer Diagnostics Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Cancer Diagnostics Service Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Cancer Diagnostics Service Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Cancer Diagnostics Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. Europe Cancer Diagnostics Service Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Cancer Diagnostics Service Market Size by Country (2024-2029) & (US$ Million)
Table 41. Asia-Pacific Cancer Diagnostics Service Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Asia-Pacific Cancer Diagnostics Service Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Cancer Diagnostics Service Market Size by Region (2024-2029) & (US$ Million)
Table 44. Latin America Cancer Diagnostics Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Latin America Cancer Diagnostics Service Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Cancer Diagnostics Service Market Size by Country (2024-2029) & (US$ Million)
Table 47. Middle East & Africa Cancer Diagnostics Service Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Middle East & Africa Cancer Diagnostics Service Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Cancer Diagnostics Service Market Size by Country (2024-2029) & (US$ Million)
Table 50. Illumina Company Detail
Table 51. Illumina Business Overview
Table 52. Illumina Cancer Diagnostics Service Product
Table 53. Illumina Revenue in Cancer Diagnostics Service Business (2018-2023) & (US$ Million)
Table 54. Illumina Recent Development
Table 55. BGI Genomics Co.,Ltd. Company Detail
Table 56. BGI Genomics Co.,Ltd. Business Overview
Table 57. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product
Table 58. BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2018-2023) & (US$ Million)
Table 59. BGI Genomics Co.,Ltd. Recent Development
Table 60. Agilent Technologies Company Detail
Table 61. Agilent Technologies Business Overview
Table 62. Agilent Technologies Cancer Diagnostics Service Product
Table 63. Agilent Technologies Revenue in Cancer Diagnostics Service Business (2018-2023) & (US$ Million)
Table 64. Agilent Technologies Recent Development
Table 65. Macrogen Company Detail
Table 66. Macrogen Business Overview
Table 67. Macrogen Cancer Diagnostics Service Product
Table 68. Macrogen Revenue in Cancer Diagnostics Service Business (2018-2023) & (US$ Million)
Table 69. Macrogen Recent Development
Table 70. Pacific Biosciences Company Detail
Table 71. Pacific Biosciences Business Overview
Table 72. Pacific Biosciences Cancer Diagnostics Service Product
Table 73. Pacific Biosciences Revenue in Cancer Diagnostics Service Business (2018-2023) & (US$ Million)
Table 74. Pacific Biosciences Recent Development
Table 75. Abbott Company Detail
Table 76. Abbott Business Overview
Table 77. Abbott Cancer Diagnostics Service Product
Table 78. Abbott Revenue in Cancer Diagnostics Service Business (2018-2023) & (US$ Million)
Table 79. Abbott Recent Development
Table 80. QIAGEN Company Detail
Table 81. QIAGEN Business Overview
Table 82. QIAGEN Cancer Diagnostics Service Product
Table 83. QIAGEN Revenue in Cancer Diagnostics Service Business (2018-2023) & (US$ Million)
Table 84. QIAGEN Recent Development
Table 85. Siemens Healthcare GmbH Company Detail
Table 86. Siemens Healthcare GmbH Business Overview
Table 87. Siemens Healthcare GmbH Cancer Diagnostics Service Product
Table 88. Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2018-2023) & (US$ Million)
Table 89. Siemens Healthcare GmbH Recent Development
Table 90. Thermo Fisher Scientific, Inc. Company Detail
Table 91. Thermo Fisher Scientific, Inc. Business Overview
Table 92. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product
Table 93. Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2018-2023) & (US$ Million)
Table 94. Thermo Fisher Scientific, Inc. Recent Development
Table 95. Applied DNA Sciences Company Detail
Table 96. Applied DNA Sciences Business Overview
Table 97. Applied DNA Sciences Cancer Diagnostics Service Product
Table 98. Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2018-2023) & (US$ Million)
Table 99. Applied DNA Sciences Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Diagnostics Service Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cancer Diagnostics Service Market Share by Type: 2022 VS 2029
Figure 3. Breast Cancer Features
Figure 4. Blood Cancer Features
Figure 5. Lung Cancer Features
Figure 6. Colorectal Cancer Features
Figure 7. Ovarian Cancer Features
Figure 8. Others Features
Figure 9. Global Cancer Diagnostics Service Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Cancer Diagnostics Service Market Share by Application: 2022 VS 2029
Figure 11. Hospitals Case Studies
Figure 12. Ambulatory Surgical Centers Case Studies
Figure 13. Diagnostic Laboratories Case Studies
Figure 14. Others Case Studies
Figure 15. Cancer Diagnostics Service Report Years Considered
Figure 16. Global Cancer Diagnostics Service Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Cancer Diagnostics Service Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Cancer Diagnostics Service Market Share by Region: 2022 VS 2029
Figure 19. Global Cancer Diagnostics Service Market Share by Players in 2022
Figure 20. Global Top Cancer Diagnostics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Cancer Diagnostics Service Revenue in 2022
Figure 22. North America Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Cancer Diagnostics Service Market Share by Country (2018-2029)
Figure 24. United States Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Cancer Diagnostics Service Market Share by Country (2018-2029)
Figure 28. Germany Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Cancer Diagnostics Service Market Share by Region (2018-2029)
Figure 36. China Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Cancer Diagnostics Service Market Share by Country (2018-2029)
Figure 44. Mexico Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Cancer Diagnostics Service Market Share by Country (2018-2029)
Figure 48. Turkey Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Cancer Diagnostics Service Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Illumina Revenue Growth Rate in Cancer Diagnostics Service Business (2018-2023)
Figure 51. BGI Genomics Co.,Ltd. Revenue Growth Rate in Cancer Diagnostics Service Business (2018-2023)
Figure 52. Agilent Technologies Revenue Growth Rate in Cancer Diagnostics Service Business (2018-2023)
Figure 53. Macrogen Revenue Growth Rate in Cancer Diagnostics Service Business (2018-2023)
Figure 54. Pacific Biosciences Revenue Growth Rate in Cancer Diagnostics Service Business (2018-2023)
Figure 55. Abbott Revenue Growth Rate in Cancer Diagnostics Service Business (2018-2023)
Figure 56. QIAGEN Revenue Growth Rate in Cancer Diagnostics Service Business (2018-2023)
Figure 57. Siemens Healthcare GmbH Revenue Growth Rate in Cancer Diagnostics Service Business (2018-2023)
Figure 58. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Diagnostics Service Business (2018-2023)
Figure 59. Applied DNA Sciences Revenue Growth Rate in Cancer Diagnostics Service Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Write comment about above report:
Related Reports
|
Biomarkers Market by Product & Service (Consumable, Service, Software), Type (Safety, Efficacy, Validation), Disease (Cancer, Infectious, Neurological), Application (Diagnostics, Drug Discovery, Personalized Medicine), Region - Global Forecast to 2028
“The growing prevalence of chronic diseases to drive the biomarkers market.’’ The global biomarkers market is expected to reach USD 104.0 billion in 2028 from USD 59.1 billion in 2023 at a CARG of 12.0%.F... |
|
Global Cancer Diagnostics Service Market Research Report 2022
This report aims to provide a comprehensive presentation of the global market for Cancer Diagnostics Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation... |
|
Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service), Application (Respiratory Diseases, HAIs, STDs, Cancer, Hepatitis), Technology (RT-PCR, INAAT), End User (Physician Office, Hospitals, ICUs) - Global Forecast to 2026
“Increasing prevalence of infectious diseases and cancer and the rising funding for R&D are driving the overall growth of the point-of-care molecular diagnostics market” The global point-of... |
|
Immuno Oncology Assays Market by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications (Lung, Breast, Colorectal, Bladder, Melanoma), Application (Research, Diagnostics) - Global Forecast to 2026
“Growing adoption of targeted therapies and rising incidence of cancer are driving the overall growth of the immuno-oncology assays market” The global immuno-oncology... |
|
Respiratory Diagnostics Market by Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021
The global respiratory diagnostics market is projected to reach USD 7.45 billion by 2021 from USD 5.24 billion in 2016, at a CAGR of 7.3% from 2016 to 2021. Increasing prevalence of respiratory diseases, growing geriatric population, and technolog... |
We are on:
Why ReportsnReports.com?
- 500,000 market research reports and growing.
- Top Fortune 500 Organizations trust us for research data.
- 24/7 support on call as well as emails.
- Your Details are safe with us.
- Free support for your research requirements.
- Report Delivery: Email
- Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays